Rhinitis and Sinusitis: A Comprehensive Updated Overview
- PMID: 41241430
- DOI: 10.1016/j.iac.2025.10.001
Rhinitis and Sinusitis: A Comprehensive Updated Overview
Conflict of interest statement
Disclosures J.S. Bernstein - nothing to declare. J.A. Bernstein - Consultant: Opella, Sanofi - other COI not directly related to content include: Investigator and consultant: ADARx, Ajou University, Allergy therapeutics, Amgen, Apogee, Areteia, ARS, Astra Zeneca, Astria, Biocyrst, Blueprint Medicine, Celldex, Cogent, CSL Behring, Eli Lilly, Escient, Evommune, Fresenius Kabi, Genentech, GSK, Incyte, Intellia, Ionis, Japan Tobacco Company, Jasper, Kalvista, Kenvue, Kymeria, Kyowa Kirin, Medscape, Merck, Nasus, Neffy, Nektar, Neopharma, Novartis, Opella, Pharming, Pharvaris, Proctor and Gamble, Regeneron, Sanofi, Takeda/Shire, Telios, Teledoc, TEVA, Yuhan, WebMD news. Consultant: Enanta, Pfizer, RAPT. Speaker: Pharming, Kalvista, CSL Behring.
Publication types
LinkOut - more resources
Full Text Sources
